Document:

Exhibit

Exhibit 10(a)

FIRST AMENDMENT TO NON-PROSECUTION AGREEMENT
WITH TENET HEALTHSYSTEM MEDICAL, INC.

The United States Department of Justice, Criminal Division, Fraud Section (“the Department”) and Tenet HealthSystem Medical, Inc. (on its behalf and on behalf of its subsidiaries) (collectively, “Tenet Subsidiary”), pursuant to authority granted by the Board of Directors of its parent, Tenet Healthcare Corporation (“Tenet”) attached hereto (Attachment A), enters into this Amendment to the Non-Prosecution Agreement (“Agreement”) dated September 30, 2016.

The terms and conditions of this Amendment to the Non-Prosecution Agreement are as follows:

1.    Paragraph 4 is amended to state as follows:

Term of the Agreement. Tenet Subsidiary’s and Tenet’s obligations under this   Agreement shall have a term of 3 years and 9 months from the date on which the independent monitor is retained by Tenet, as described below (the “Term”). Tenet Subsidiary agrees, however, that in the event the Department determines, in its sole discretion, that Tenet Subsidiary or Tenet, or any of Tenet’s subsidiaries or affiliates has knowingly violated any provision of this Agreement, subject to Paragraph 12, below, an extension or extensions of the term of the Agreement may be imposed by the Department, in their sole discretion, for up to a total additional time period of three months, without prejudice to the Department’s right to proceed as provided in Paragraphs 13-14, below. Any extension of this Agreement extends all terms of the Agreement, including the terms of the monitorship in Attachment C, for an equivalent period. Conversely, in the event the Department finds, in its sole discretion, that there exists a change in circumstances sufficient to eliminate the need for a monitorship as described in Attachment C, or that other provisions of this Agreement have been satisfied, the monitorship or the Term of this Agreement may be terminated early.

2.    In all other respects, the Non-Prosecution Agreement shall remain in full force 
and effect.

FOR THE DEPARTMENT OF JUSTICE:

	
					
	Date
	7/19/2018
	 
	By:
	/s/ Sally B. Molloy

	 
	 
	 
	 
	SANDRA L. MOSER

	 
	 
	 
	 
	Acting Chief, Fraud Section

	 
	 
	 
	 
	Criminal Division

	 
	 
	 
	 
	United States Department of Justice

	 
	 
	 
	 
	 

	 
	 
	 
	 
	Robert A. Zink

	 
	 
	 
	 
	Acting Principal Deputy Chief, Fraud Section

	 
	 
	 
	 
	 

	 
	 
	 
	 
	Joseph S. Beemsterboer

	 
	 
	 
	 
	Deputy Chief, Fraud Section

	 
	 
	 
	 
	 

	 
	 
	 
	 
	Sally B. Molloy

	 
	 
	 
	 
	Assistant Deputy Chief, Fraud Section

AGREED AND CONSENTED TO:

Tenet HealthSystem Medical, Inc.*

	
					
	Date
	June 1, 2018
	 
	BY:
	/s/ Audrey Andrews

	 
	 
	 
	 
	Audrey Andrews

	 
	 
	 
	 
	Senior Vice President and

	 
	 
	 
	 
	General Counsel

	 
	 
	 
	 
	Tenet Healthcare Corporation

	 
	 
	 
	 
	 

	Date
	June 4, 2018
	 
	BY:
	/s/ Kathryn H. Ruemmler

	 
	 
	 
	 
	Kathryn H. Ruemmler

	 
	 
	 
	 
	Latham & Watkins LLP

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

_________________________

* Where Tenet is indicated in the Amendment to the Agreement and Agreement, Tenet Subsidiary is acting on behalf of Tenet

EXHIBIT A
TENET HEALTHCARE CORPORATION
Resolutions Adopted at a  
Meeting of the Board of Directors 

WHEREAS, on September 30, 2016, Tenet HealthSystem Medical, Inc. (“THSM”), a wholly-owned subsidiary of Tenet Healthcare Corporation (the “Company”) entered into a Non-Prosecution Agreement with the U.S. Department of Justice and the U.S. Attorney’s Office for the Northern District of Georgia (the “Department”);
WHEREAS, in November 2017, the Department provided notice to the Company’s outside counsel and its Board of Directors (the “Board”) of the Department’s determination that Tenet and THSM had breached the terms of the NPA by failing to promptly report to the Department certain reportable events as required by Paragraph 5.e. of the NPA;
WHEREAS, in April 2018, after engaging in dialogue and consideration of the nature, facts and circumstances surrounding the breach, as well as the Company’s actions and efforts to remediate the situation, the Department determined that a nine-month extension of the term of the NPA, including the monitorship described therein, is an appropriate remedy and proposed a form of Amendment to the Non-Prosecution Agreement (the “Amendment”) for the Board’s consideration; and 
WHEREAS, the Board has considered the form of Amendment and, based upon the advice and recommendations of the Company’s external counsel and its management, the Board has determined to authorize THSM to enter into the Amendment for and on behalf of itself and the Company.
NOW THEREFORE, BE IT RESOLVED that each of (i) the Company’s Executive Chairman and Chief Executive Officer, its Senior Vice President and General Counsel or any Senior Vice President or any Vice President, and (ii) the Company’s external counsel from Latham & Watkins LLP, be, and each of them hereby is, authorized to execute the Amendment for and on behalf of THSM and the Company.

SECRETARY’S CERTIFICATION

TENET HEALTHCARE CORPORATION

I, Anthony L. Shoemaker, the duly appointed Corporate Secretary of Tenet Healthcare Corporation (the “Company”), a corporation organized under the laws of the State of Nevada, hereby certify that attached as Exhibit A is a true and correct copy of a resolution approved by the Board of Directors of the Company at a meeting on May 3, 2018:

IN WITNESS WHEREOF, I have executed this certificate in my capacity as the Company’s Corporate Secretary this 1st day of June, 2018.

/s/ Anthony L. Shoemaker    
Anthony L. Shoemaker
Corporate SecretaryExhibit

Exhibit 10(b)

TENET HEALTHCARE 2008 STOCK INCENTIVE PLAN 
TERMS AND CONDITIONS OF
RESTRICTED STOCK UNIT AWARD

The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2008 Stock Incentive Plan, as amended (the “Plan”) to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs.
On June 29, 2018 (the “Grant Date”), the Committee granted Ronald A. Rittenmeyer, (“You”), RSUs. The RSUs were granted by the Committee subject to the terms and conditions set forth below in this certificate (the “Certificate”). The RSUs are also subject to the terms and conditions of the Plan, which is incorporated herein by this reference. Each capitalized term not otherwise defined herein will have the meaning given to such term in the Plan.
		
	1.
	Grant. The Committee has granted You RSUs representing 51,146 Shares in consideration for services to be performed by You for the Company or a Subsidiary of the Company.

		
	2.
	Vesting. Except as otherwise provided in Section 3 below, the RSUs will vest in equal installments according to the following schedule; provided You remain an employee of the Company on each applicable vesting date:  September 1, 2018, December 1, 2018, March 1, 2019, June 1, 2019, September 1, 2019, December 1, 2019 and February 28, 2020. 

		
	3.
	Termination of Employment.  All unvested RSUs will vest in the event Your employment is terminated for any of the following reasons: 

		
	•
	Death; 

		
	•
	Disability (as defined in the Employment Agreement by and between You and the Company, effective as of March 1, 2018 (the “Employment Agreement”)); and

		
	•
	A termination of Your employment by the Company other than for Cause or by you for Good Reason (as such terms are defined in the Employment Agreement).  

		
	4.
	Tax Withholding. Except as otherwise provided in the Employment Agreement, upon the vesting of Your RSUs, Your RSUs will be settled in Shares within 30 days and You will recognize ordinary income. The Company is required to withhold payroll taxes due with respect to that ordinary income. Pursuant to the Plan, at its option the Committee either may (a) have the Company withhold Shares having a Fair Market Value equal to the amount of the minimum tax withholding or (b) require You to pay to the Company the amount of the tax withholding.

		
	5.
	Rights as Shareholder. You will not have any rights of a shareholder prior to the vesting of the RSUs, at which time You will have all of the rights of a shareholder with respect to the Shares received upon the vesting of those RSUs, including the right to vote those Shares and receive all dividends and other distributions, if any, paid or made with respect thereto. Any Shares distributed as dividends with respect to the Shares subject to the RSUs will be subject to the same vesting schedule as the underlying RSUs.

		
	6.
	Transferability. The RSUs generally may not be transferred, assigned or made subject to any encumbrance, pledge, or charge. Limited exceptions to this rule apply in the case of death, divorce, or gift as provided in Section 12.3 of the Plan.

		
	7.
	Effect on Other Employee Benefit Plans. The value of the RSUs evidenced by this Certificate will not be included as compensation, earnings, salaries, or other similar terms used when calculating Your benefits under any employee benefit plan sponsored by the Company or a Subsidiary, except as such plan otherwise expressly provides.

		
	8.
	No Employment Rights. Nothing in this Certificate will confer upon You any right to continue in the employ or service of the Company or any Subsidiary or affect the right of the Company or a Subsidiary to terminate Your employment at any time with or without cause.

		
	9.
	Amendment. By written notice to You, the Committee reserves the right to amend the Plan or the provisions of this Certificate provided that no such amendment will impair in any material respect Your rights under this Certificate without Your consent except as required to comply with applicable securities laws or Section 409A of the Code.

		
	10.
	Severability. If any term or provision of this Certificate is declared by any court or government authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any term or provision of this Certificate not declared to be unlawful or invalid. Any term or provision of this Certificate so declared to be unlawful or invalid shall, if possible, be construed in a manner that will give effect to such term or provision to the fullest extent possible while remaining lawful and valid.

		
	11.
	Construction. A copy of the Plan has been made available to You and additional copies of the Plan are available upon request to the Company’s Corporate Secretary at the Company’s principal executive office during normal business hours. To the extent that any term or provision of this Certificate violates or is inconsistent with an express term or provision of the Plan, the Plan term or provision shall govern and any inconsistent term or provision in this Certificate shall be of no force or effect.

		
	12.
	Binding Effect and Benefit. This Certificate shall be binding upon and, subject to the terms and conditions hereof, inure to the benefit of the Company, its successors and assigns, and You and Your successors and assigns.

		
	13.
	Entire Understanding. This Certificate embodies the entire understanding and agreement of the Company and You in relation to the subject matter hereof, and no promise, condition, representation or warranty, expressed or implied, not herein stated, shall bind the Company or You.

		
	14.
	Governing Law. This Certificate shall be governed by, and construed in accordance with, the laws of the State of Nevada.

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]